Introductory Chapter: Current Challenges in the Management of Patients with Acute and Chronic Pancreatitis by Garbuzenko, Dmitry
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Introductory Chapter: Current 
Challenges in the Management of 
Patients with Acute and Chronic 
Pancreatitis
Dmitry Garbuzenko
1. Introduction
As part of medical science, pancreatology reflects the level of technological 
progress and modern achievements in the natural sciences. Over the past five 
centuries, since A. Vesalius first described the pancreas and its topography, tremen-
dous work has been done to determine the physiological role of the pancreas in the 
process of digestion, to study the causes and patterns characteristic of pancreatic 
diseases, and to find the ways of treatment. In this regard, the current challenges in 
modern pancreatology include the development and implementation of methods 
for early and accurate diagnosis and selection of the optimal tactics for treating 
patients with acute and chronic pancreatitis.
2. Acute pancreatitis
Acute pancreatitis is an acute surgical disease of the pancreas, which consists 
of primary edema or aseptic necrosis of pancreatic parenchyma with the possible 
infection of the pancreas and retroperitoneal tissue. Acute pancreatitis is one of 
the most common causes of acute abdomen, ranking third after acute appendicitis 
and acute cholecystitis. Along with an increase in the number of patients with acute 
pancreatitis in recent years, there has been a tendency to an increase in the inci-
dence of its destructive forms [1].
Despite the progress achieved in improving the diagnostics of acute pancreatitis, 
pathogenetically substantiated intensive therapy, antibiotic therapy, and minimally 
invasive surgical treatment, mortality in acute pancreatitis has remained at the 
same level over the past decades. Moreover, while the overall mortality is within 
3–6%, depending on the fluctuation of destructive pancreatitis incidence, the mor-
tality rate is 15–30% in pancreatic necrosis, is 85% in infected pancreatic necrosis, 
and reaches 100% in fulminant acute pancreatitis [2].
Currently, the immediate prescription of antibiotics in severe forms of acute 
pancreatitis is no longer debatable. However, there are still different opinions on 
the effectiveness of existing methods of delivering antibacterial drugs to the site of 
pancreatic destruction. The situation is aggravated by the increasing polyresistance 
of microorganisms to most antimicrobial chemotherapeutic agents [3]. According 
to modern conception, immune disorders are considered as a factor that largely 
determines the course of acute pancreatitis, helps maintain the inflammatory 
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process, and reduces the effectiveness of reparative mechanisms [4]. In this regard, 
an urgent problem is the early prevention of infection in severe pancreatitis, timely 
detection and correction of immunological deficiency, and timely diagnosis and 
treatment of septic complications including systemic inflammatory response, 
multiple organ failure, and sepsis [5].
At present, some certainty has been achieved in approaches to the manage-
ment of patients with acute pancreatitis. Nevertheless, one of the most important 
problems is to choose the tactics of surgical treatment. Mild pancreatitis does not 
require surgery and quickly disappears after using standard conservative treatment 
and eliminating the etiological factor. However, in 10–20% of patients, surgeons 
encounter severe pancreatic necrosis, which is essentially a hypermetabolic syn-
drome of multiple organ failure. While the questions about the indications and the 
most favorable time period for surgical treatment are mostly answered in severe 
pancreatitis, it is still not obvious what the most appropriate techniques and type of 
surgery are. Along with experience in minimally invasive interventions, it becomes 
clear that their active implementation does not solve all the problems of acute 
pancreatitis treatment and requires further research [6].
Thus, the most important objective in improving treatment results in acute 
pancreatitis is the use of standardized approaches to diagnostics and treatment of 
various forms of the disease and its complications, taking into account the modern 
generally accepted international classification [7].
3. Chronic pancreatitis
Chronic pancreatitis is characterized by inflammation of the pancreas, which 
is replaced by fibrosis and progressing pancreatic tissue destruction. According to 
the M-ANNHEIM classification, the following etiological causes are involved in the 
pathogenesis of chronic pancreatitis: alcohol consumption, nicotine consumption, 
nutrition factors, hereditary factors, efferent duct factors, immunological risk 
factors, and miscellaneous (tropical chronic pancreatitis, primary hypercalcemia, 
hyperparathyroidism, hyperlipidemia) [8]. Clinically, at an early stage of the 
disease, abdominal pain or recurrent episodes of acute pancreatitis usually prevail, 
whereas, at a late stage, symptoms are associated with exocrine and/or endocrine 
insufficiency. Consequently, the three main clinical signs of chronic pancreatitis 
are pain, maldigestion, and diabetes. The incidence is estimated at 2–10/100000 
and tends to increase [9]. In addition, there are many patients with characteristic 
symptoms but with undiagnosed chronic pancreatitis.
Chronic pancreatitis is not only an urgent medical problem but also a signifi-
cant economic burden that has a profound effect on social life and the structure 
of employment [10]. In the United States in 2000, there were 327,000 hospital-
izations and 532,000 visits to doctors due to chronic pancreatitis, which cost 
$2.5 billion [11].
Diagnostics and follow-up of patients with chronic pancreatitis are based 
on both the clinical picture and imaging methods, and the diagnosis of chronic 
pancreatitis at an early stage is a clinical problem. Historically, diagnostic methods 
included ultrasound imaging of the abdominal organs, endoscopic ultrasound 
(EUS), ultrasound with contrast enhancement (CEUS), endoscopic retrograde 
cholangiopancreatography (ERCP), magnetic resonance imaging (MRI), and 
computed tomography (CT). While ultrasound is considered the least accurate, 
and EUS is one of the most sensitive methods [12], ERCP is no longer a diagnostic 
test for chronic pancreatitis [13]. EUS is highly accurate in assessing the paren-
chyma and ductal system of the pancreas and is also very useful in identifying 
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complication characteristic of chronic pancreatitis [14]. CEUS helps diagnose cystic 
and solid lesions of the pancreas, which are associated with chronic pancreatitis. It 
was convincing in 90% of cases, so it may be considered as a first-line method of 
visualization [15]. MRI makes it possible to accurately determine the morphological 
and functional changes of the pancreas and is a recognized method for detecting 
calculi in pancreatic ducts [16]. At the same time, the calcinates may be determined 
by means of portal-phase contrast-enhanced CT with moderate sensitivity and very 
high specificity (close to 100%) [17].
The degree of exocrine and endocrine pancreatic insufficiency is also important 
to determine when diagnosing chronic pancreatitis. The so-called direct or invasive 
methods for detecting exocrine insufficiency, such as the Lund test, are a thing 
of the past. Currently, the “gold standard” is 3-day fecal fat quantification and 
determination of the coefficient of fat absorption. Due to the cumbersomeness and 
unpleasantness of the method for both patient and laboratory personnel, it is very 
rarely used in everyday clinical practice. Other methods for diagnosing exocrine 
pancreatic insufficiency include measuring the concentration of fecal elastase 1, the 
13C-mixed triglycerides (13C-MTG) breath test, a test based on analysis of pancre-
atic juice after secretin/cerulein stimulation, and others [18].
In the absence of complications, the main goal of treating chronic pancreatitis 
is the effective correction of its main manifestations: pain, maldigestion, and 
diabetes. Abdominal pain is usually severe and often occurs after a meal, which, 
despite adequate enzyme replacement therapy, leads to malnutrition. Although 
pain may be associated with strictures and stones in the main pancreatic duct, 
new investigations have questioned the importance of micro- and macrostruc-
tural pathological changes. Currently, the neurogenic causes of pain are widely 
discussed, which should be taken into account when choosing the method of pain 
relief for patients [19]. Malnutrition that is related to a lack of enzymes leads 
not only to weight loss but also to a certain deficiency of vitamins and nutrients 
that are necessary for normal physiological functioning. Malnutrition in chronic 
pancreatitis is often overlooked. It is very important that gastroenterologists 
consider this fact while making a differential diagnosis in patients with weight 
loss [20]. Diabetes of the exocrine pancreas is a form of diabetes that occurs due 
to pancreatic disease. It is more common than previously thought. A recent study 
found that in 1.8% of adults with diabetes, it should be classified as diabetes of 
the exocrine pancreas. However, in most cases, it is referred to as type 2 diabetes. 
Patients with diabetes of the exocrine pancreas have varying degrees of exocrine 
and endocrine dysfunction. Damage to the islets of Langerhans affects the secre-
tion of hormones by the pancreatic polypeptide, β-, and α-cells. Polypeptides 
and a low concentration of insulin and glucagon promote sharp fluctuations in 
the glucose level. This form of “fragile diabetes” in patients with diabetes of the 
exocrine pancreas may lead to worse glycemic control in comparison with type 2 
diabetes [21].
If conservative therapy is not effective, it is possible to apply the endoscopic 
treatment, conduction anesthesia or neurolysis, or surgical techniques. Endoscopic 
methods are usually required for the elimination of the main pancreatic duct 
obstruction caused by a stricture or stone. In addition, endoscopy is the first-choice 
treatment of pancreatic pseudocysts [22]. Celiac plexus block is useful for elimi-
nating pain. It is performed via a gastric approach using EUS guidance and has 
high success rates and relatively low complication rates [23]. Surgical treatment of 
chronic pancreatitis is aimed primarily at relieving pain, improving the patient’s 
quality of life, and treating complications. Surgical operations include decompres-
sion (drainage) of the main pancreatic duct, various types of pancreatic resections, 
their combination, and neuroablation [24].
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In recent years, important advances have been made in understanding the patho-
genesis of chronic pancreatitis. Although the disease is still difficult to treat, the 
development of new approaches has reduced the severity of clinical manifestations 
and improved the life quality of patients with chronic pancreatitis.
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